NP
Nutra Pharma Corp.
NPHC · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $716.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
51 /100
Fair P/S 3.46x
P/FCF N/A
P/FFO N/A
Growth
100 /100
Growing Rev. growth 61.32%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak FCF margin 507.09%
Op. margin 790.74%
Gross margin 50.38%
Quality
60 /100
Average ROA 870.25%
Asset turnover 0.33x
ROIC 18.47%
Debt
0 /100
High Int. coverage -5,917.43x
Current ratio 0.02x
Net debt/EBITDA N/A
Stability
16 /100
Unstable Profitable years 1
EPS volatility 1,038.70%
Beta -2.77x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na NPHC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Michael D. Flax
Employees
6
Headquarters
Boca Raton